Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM)

American Journal of Surgery

Volumn 188, Issue 5, 2004, Pages 575-579

  Brewster, Luke P ^a,b   Brey, Eric M ^a,b   Tassiopoulos, Apostolos K ^a,b   Xue, Lian ^a,b   Maddox, Ewa ^c   Armistead, David ^c   Burgess, Wilson H ^c   Greisler, Howard P ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Clearant Inc   (United States)

Author keywords

Angiogenesis; Fibroblast growth factor 1; Mitogen; Re endothelialization; Site directed mutagenesis

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; GROWTH FACTOR; HEPARIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; CULTURE MEDIUM; DOG; ENDOTHELIUM CELL; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANALYSIS OF VARIANCE; ANIMALS; BASE SEQUENCE; CAROTID ARTERIES; CELL PROLIFERATION; CELLS, CULTURED; DOGS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 1; HEPARIN; MITOGENS; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROBABILITY; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 8544223540     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2004.07.012     Document Type: Article

References (23)

1. A.D. Callow Current status of vascular grafts Surg Clin North Am 62 1982 501 513
2. E.S. Crawford, R.A. Bomberger, D.H. Glaeser Aortoiliac occlusive disease: factors influencing survival and function following reconstructive operation over a twenty-five year period Surgery 90 1981 1055 1067
3. R. Virmani, F. Liistro, G. Stankovic Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans Circulation 106 2002 2649 2651
4. M.R. Mayberg, S. London, J. Rasey, C. Gajdusek Inhibition of rat smooth muscle proliferation by radiation after arterial injury: temporal characteristics in vivo and in vitro Radiat Res 153 2000 153 163
5. M.M. Sholley, G.P. Ferguson, H.R. Seibel Mechanisms of neovascularization Vascular sprouting can occur without proliferation of endothelial cells Lab Invest 51 1984 624 634
6. R. Virmani, A. Farb, F.D. Kolodgie Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences Herz 27 2002 1 6
7. M. Deutsch, J. Meinhart, T. Fischlein Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience Surgery 126 1999 847 855
8. H.P. Greisler, D.J. Cziperle, D.U. Kim Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type I pretreatment Surgery 112 1992 244 254
9. S.S. Kang, C. Gosselin, D. Ren, H.P. Greisler Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions Surgery 118 1995 280 286
10. W.H. Burgess, T. Mehlman, R. Friesel Multiple forms of endothelial cell growth factor J Biol Chem 260 1985 11389 11392
11. P.K. Shireman, L. Xue, E. Maddox The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue J Vasc Surg 31 2000 382 390
12. A.D. DiGabriele, I. Lax, D.I. Chen Structure of a heparin-linked biologically active dimer of fibroblast growth factor Nature 393 1998 812 817
13. D.H. Damon, R.R. Lobb, P.A. D'Amore, J.A. Wagner Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life J Cell Physiol 138 1989 221 226
14. P. Wong, B. Hampton, E. Szylobryt Analysis of putative heparin-binding domains of fibroblast growth factor-1 using site-directed mutagenesis and peptide analogues J Biol Chem 270 1995 25805 25811
15. E. Raulo, M.A. Chernousov, D.J. Carey Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM): identification as N-syndecan (syndecan-3) J Biol Chem 269 1994 12999 13004
16. T. Kojima, A. Katsumi, T. Yamazaki Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor J Biol Chem 271 1996 5914 5920
17. L. Xue, A.K. Tassiopoulos, S.K. Woloson Construction and biological characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering J Vasc Surg 33 2001 554 560
18. J.I. Zarge, P. Huang, V. Husak Fibrin glue containing fibroblast growth factor type-1 and heparin with autologous endothelial cells reduces intimal hyperplasia in a canine carotid artery balloon injury model J Vasc Surg 25 1997 840 848
19. T. Spivak-Kroizman, M.A. Lemmon, I. Dikic Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation Cell 79 1994 1015 1024
20. B.S. Hampton, D.R. Marshak, W.H. Burgess Structural and functional characterization of full-length heparin-binding growth associated molecule Mol Biol Cell 3 1992 85 93
21. W. Fang, N. Hartmann, D.T. Chow Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer J Biol Chem 267 1992 25889 25897
22. K. Laaroubi, J. Delbe, F. Vacherot Mitogenic and in vitro angiogenic activity of human recombinant heparin affinity regulatory peptide Growth Factors 10 1994 89 98
23. M. Chernousov, D.J. Carey N-syndecan (syndecan-3) from neonatal rat brain binds basic fibroblast growth factor J Biol Chem 268 1993 16810 16814